Related Experiment Videos
Helicase inhibition by anthracycline anticancer agents.
1Department of Medicine, University of Maryland Cancer Center, Baltimore 21201.
Molecular Pharmacology
|June 1, 1992
Summary
Anthracycline antibiotics potently inhibit helicase activity, crucial for DNA replication and transcription. This interference may explain their anti-cancer effects and cellular resistance mechanisms.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Helicases are vital enzymes that unwind double-stranded DNA for replication and transcription.
- Anthracycline antibiotics are known to stabilize double-stranded DNA via intercalation.
- This stabilization mechanism suggested potential interference with helicase function.
Purpose of the Study:
- To investigate the inhibitory effects of anthracycline antibiotics on helicase activity.
- To determine the potency of various anthracyclines against helicase enzymes.
- To explore the implications of helicase inhibition in the context of anthracycline's anti-cancer mechanisms.
Main Methods:
- Utilized a 32P-labeled 17-mer DNA substrate annealed to M13mp19(+) circular single-stranded DNA.
- Assessed the inhibitory effects of anthracycline antibiotics on SV40 large T antigen helicase activity.
- Determined half-maximal inhibitory concentration (IC50) values for multiple anthracyclines.
Main Results:
- Anthracycline antibiotics significantly inhibited SV40 large T antigen helicase activity.
- Potent inhibition was observed with IC50 values ranging from 2 x 10(-7) M (nogalamycin) to 6 x 10(-6) M (menogaril).
- Doxorubicin also inhibited partially purified helicases from HeLa and FM3A cells.
Conclusions:
- Anthracycline antibiotics directly inhibit helicase activity, a key cellular process.
- Helicase inhibition by anthracyclines could contribute to their anti-cancer potency and drug specificity.
- This mechanism may also shed light on cellular resistance to anthracycline-based therapies.